CRIS Current Research Information System

MUSIANI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.076
NA - Nord America 5.974
EU - Europa 4.944
AF - Africa 340
SA - Sud America 248
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 17.589
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.921
CN - Cina 1.838
VN - Vietnam 1.644
SG - Singapore 1.460
GB - Regno Unito 1.364
DE - Germania 633
IT - Italia 592
UA - Ucraina 572
SE - Svezia 553
HK - Hong Kong 345
IN - India 335
FR - Francia 332
RU - Federazione Russa 302
BR - Brasile 179
IE - Irlanda 176
JP - Giappone 129
KR - Corea 104
ZA - Sudafrica 103
EE - Estonia 93
CH - Svizzera 81
TG - Togo 78
SC - Seychelles 54
CI - Costa d'Avorio 52
FI - Finlandia 48
NL - Olanda 45
BG - Bulgaria 41
BE - Belgio 35
CA - Canada 35
IR - Iran 30
NG - Nigeria 30
AR - Argentina 28
TH - Thailandia 19
GR - Grecia 18
IQ - Iraq 18
PH - Filippine 18
JO - Giordania 17
AT - Austria 16
BD - Bangladesh 15
ID - Indonesia 15
RO - Romania 13
TR - Turchia 13
UZ - Uzbekistan 13
PK - Pakistan 11
SA - Arabia Saudita 11
TW - Taiwan 11
MX - Messico 10
EC - Ecuador 8
LB - Libano 8
CL - Cile 7
PL - Polonia 7
CO - Colombia 6
EG - Egitto 6
PY - Paraguay 6
AZ - Azerbaigian 5
ES - Italia 5
UY - Uruguay 5
EU - Europa 4
MY - Malesia 4
TN - Tunisia 4
VE - Venezuela 4
DZ - Algeria 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
AU - Australia 2
BO - Bolivia 2
ET - Etiopia 2
KZ - Kazakistan 2
OM - Oman 2
PS - Palestinian Territory 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
ZM - Zambia 1
Totale 17.589
Salva come PNG Salva come JPEG
Città #
Southend 1.162
Singapore 925
Ashburn 575
Chandler 541
Dong Ket 501
Fairfield 455
Jacksonville 430
Hong Kong 327
Hefei 317
San Jose 282
Ho Chi Minh City 280
Wilmington 260
Princeton 246
Ann Arbor 237
Woodbridge 236
Seattle 228
Hanoi 221
Houston 214
Beijing 190
Dublin 174
Boardman 164
Cambridge 160
Santa Clara 143
Tokyo 125
Westminster 119
Padova 118
Lauterbourg 113
Nanjing 108
Berlin 94
Seoul 87
Los Angeles 86
Medford 79
Lomé 78
Bern 74
Buffalo 72
Milan 69
Mülheim 69
New York 67
Saint Petersburg 66
Shenyang 55
Abidjan 52
Jinan 52
Mahé 52
Helsinki 46
Changsha 44
Haiphong 44
Shanghai 43
Sofia 41
Dallas 40
Redwood City 40
Tianjin 38
Bengaluru 37
Guangzhou 37
Nanchang 37
Bologna 35
Brussels 35
Zhengzhou 33
Abeokuta 30
Da Nang 29
Hangzhou 29
Florence 28
Hebei 28
Verona 26
Bremen 24
Jiaxing 24
Des Moines 21
Olalla 20
San Diego 20
Taizhou 19
Paris 18
Amman 17
Dearborn 17
Toronto 17
Norwalk 16
Phoenix 16
Shenzhen 16
Frankfurt am Main 15
The Dalles 15
Kunming 14
Ningbo 14
Redondo Beach 14
Wuhan 14
San Venanzo 13
Yubileyny 13
Haikou 12
Hyderabad 12
Rome 12
São Paulo 12
Taiyuan 12
Falls Church 11
Kuban 11
London 11
Pune 11
Thái Nguyên 11
Ardabil 10
Chengdu 10
Rio de Janeiro 10
Tappahannock 10
Thái Bình 10
Turin 10
Totale 11.155
Salva come PNG Salva come JPEG
Nome #
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 245
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 237
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 222
Bio-chemiluminescent miniaturized biosensors 218
Bio- and chemiluminescence imaging in analytical chemistry 214
A miniaturized multiplexed analytical device with chemiluminescence "contact" imaging detection for diagnostic applications 203
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 200
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 198
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 197
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 197
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 196
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 194
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 192
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 191
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 186
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 186
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 184
Analysis of HPV16 E6*I-II transcripts in cervical samples 184
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 183
A proteomic approach to the analysis of B19 capsid proteins 183
Combined fluorescent DNA in situ hybridization and chemiluminescent immunohistochemistry for the co-localization of mucosal human papillomavirus and malignant melanoma 182
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 180
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 179
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 175
Analisi della competenza funzionale di cloni genomici di parvovirus B19 175
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 175
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 172
Recurrent erythema in patients with long-term parvovirus B19 infection 172
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 171
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 171
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 164
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 163
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 162
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 162
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 161
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 161
Parvovirus B19-derived fetal complications following gestational infection. 161
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 160
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 159
Analysis of the functional competence of genomic clones of Parvovirus B19 159
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 158
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 155
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 155
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 155
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 154
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 154
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 153
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 153
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 152
Evidence of human bocavirus viremia in healthy blood donors. 151
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 150
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 150
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 150
No correlation between cytomegalovirus and alopecia areata [2] 149
Diagnosi virologica di infezione da papillomavirus umani 148
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 148
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 148
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 148
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 148
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 148
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 147
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 147
Molecular luminescence imaging 145
Development of a miniaturized analytical device employing luminescence “contact” imaging detection for parvovirus B19 infection diagnosis 144
Human papillomavirus in melanoma: reply from authors 144
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 142
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 141
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 141
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 140
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 140
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la colocalizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 139
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 139
Catalytic partial oxidation of CH4-H2mixtures over Ni foams modified with Rh and Pt 139
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 136
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 136
Implicazioni nella progressione della patologia cervicale 135
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 132
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 128
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 128
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 127
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 127
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 127
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 126
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 126
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 125
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 125
Multiplex chemiluminescence microscope imaging of P16INK4A and HPV DNA as biomarker of cervical neoplasia 125
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 123
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 123
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 121
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 121
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 121
Detection of parvovirus B19 IgG: choice of antigens and serological tests 118
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 117
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 115
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 115
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 114
Quantitative immunohistochemistry and in situ hybridisation imaging procedures with luminescence detection: a new potential diagnostic tool 113
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 112
Luminescence detection in point-of-care testing devices 111
Totale 15.576
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.016 0 0 0 0 0 0 0 0 0 107 108 801
2021/20222.130 164 110 140 224 179 116 22 116 67 226 354 412
2022/20232.297 247 339 126 272 177 139 57 137 358 45 236 164
2023/2024798 42 94 39 128 44 165 108 63 18 33 21 43
2024/20252.057 80 359 221 144 304 112 225 45 17 53 60 437
2025/20264.541 350 712 536 427 605 303 360 116 886 246 0 0
Totale 17.895